AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Estrogen still an option for osteoporosis treatment in selected women, expert says. (Breast Cancer Risk at Issue).

OB GYN News

| November 15, 2002 | Zoler, Mitchel L. | COPYRIGHT 2002 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

SAN ANTONIO -- Estrogen is not finished as a treatment for osteopenia or osteoporosis in postmenopausal women, despite the dramatic results from the Women's Health Initiative study, according to Dr. Susan L. Greenspan.

Hormone replacement therapy (HRT), in the form of either unopposed estrogen or estrogen plus a progestin, is an option for selected women, she said at the annual meeting of the American Society for Bone and Mineral Research.

The results from a recent randomized, controlled study with 373 women showed that combined treatment with HRT and alendronate (Fosamax) was more effective than either agent alone for improving bone mineral density in older postmenopausal women, reported Dr. Greenspan, who is on the speakers' bureau for Merck, which markets Fosamax. Dr. Greenspan said she does not receive funding from companies that manufacture estrogen products.

Other experts do not agree that HRT is suitable for even a select population of women at high risk for osteoporosis. Results from the Women's Health Initiative (WHI) study clearly showed that estrogen reduces a woman's fracture risk, but it's not now possible to dearly sort out the breast cancer risk, said Dr. John A. Robbins, a principal investigator in the WHI study and a professor of medicine at the University of California, Davis.

"Even for women with clear osteoporosis, I would just treat them with a bisphosphonate and not with estrogen. Why take the risk of using estrogen?" said Dr. Robbins, who said he has no financial ties to companies that market bisphosphonates.

Recent results from the Women's Health Initiative study showed that the use of estrogen plus progestin was associated with an unacceptably high risk of breast cancer, stroke, and pulmonary embolism. But these findings were ...

Related articles from newspapers, magazines, journals, and more
WHI researchers defend their findings on HRT: some workshop attendees criticize...
Magazine article from: OB GYN News Moon, Mary Ann November 15, 2002 700+ words
...researchers in the Women's Health Initiative clinical trial. The only firm...combined estrogen-progestin HRT should not be taken solely...Health. But few women take HRT for those reasons alone. This...remaining millions who use HRT to alleviate menopausal symptoms...
Study questions HRT's benefits on quality of life: findings may not be...
Magazine article from: OB GYN News Wachter, Kerri April 15, 2003 700+ words
...data from the Women's Health Initiative. Researchers found no...replacement therapy (HRT) in the past. The study...arm of the Women's Health Initiative (WHI) last summer...cancer associated with HRT use. These risks outweighed...
Combination HRT linked to dementia in older women: findings reinforce need to...
Magazine article from: OB GYN News Tucker, Miriam E. July 1, 2003 700+ words
...new analysis of data from the Women's Health Initiative (JAMA 2891201:2651-62, 2003...the risk of dementia. For women taking HRT around the menopausal age and for a relatively...Advisory Panel is now drafting a set of HRT guidelines that will be based on all the...
HRT: the risks: what the recent Million Women Study means for...
Magazine article from: Nursing Standard Lynch, Elizabeth August 27, 2003 700+ words
...thrombosis. New concerns over HRT surfaced last year when...American study, the Women's Health Initiative, was stopped prematurely...breast cancer in women using HRT (Writing Group for the Women's Health Initiative 2002). But the US results...
HRT -- To Be Continued?
Magazine article from: OB GYN News GOLDSTEIN, SIDNEY October 15, 2000 700+ words
...The whole premise behind long-term HRT must be seriously questioned given the...of new coronary events upon initiating HRT. The Women's Health Initiative continues, with the possibility that HRT's early adverse effects will be offset...
Advisory issued on HRT and heart disease.
Magazine article from: Contraceptive Technology Update October 1, 2001 700+ words
...looking to the Womens Health Initiative to offer definitive information on the issue of HRT and cardiovascular disease...preventive role for HRT in CVD, notes Utian...such as the Womens Health Initiative, HRT should not be prescribed...
Study raises questions about HRT in diabetic women.
Newspaper article from: Biotech Week January 1, 2003 700+ words
...recent heart attack, HRT was associated with...results from the Women's Health Initiative (WHI), a randomized...disease in women taking HRT compared with women...important question about HRT in diabetic women...2002, the Women's Health Initiative trial was stopped when...
Study raises questions about HRT in diabetic women.(Brief Article)
Newspaper article from: Diabetes Week December 30, 2002 700+ words
...recent heart attack, HRT was associated with...results from the Women's Health Initiative (WHI), a randomized...disease in women taking HRT compared with women...important question about HRT in diabetic women...2002, the Women's Health Initiative trial was stopped when...
For more facts and information, see all results

Source: HighBeam Research, Estrogen still an option for osteoporosis treatment in selected...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA